HiRo
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An RNA therapeutics startup targeting genetic and metabolic diseases.
Genetics & GenomicsMetabolic
Technology Platform
An integrated RNA platform for designing, optimizing, and delivering therapeutic RNA molecules, including siRNA and mRNA, to target tissues.
Opportunities
Riding the wave of validated RNA modality success to develop potent, specific therapies for diseases with high unmet need.
Risk Factors
Early-stage technology and platform risk, particularly around delivery and manufacturing, in a field with intense IP competition.
Competitive Landscape
Enters a high-innovation but competitive field dominated by well-established Western companies with significant head starts in technology and clinical validation.